Artivion VP Horton sells $24k in shares

try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Stocks recover a chunk of their losses, still in the red on Middle East conflict Gold slips on stronger dollar; safe haven demand remains high amid Iran conflict Oil pares some gains as Trump says U.S. to escort tankers through Strait of Hormuz JPMorgan names winner and loser sectors from Iran conflict (South Africa Philippines Nigeria) Artivion VP Horton sells $24k in shares By Insider Trading Published 03/03/2026, 03:35 PM Artivion VP Horton sells $24k in shares 0 AORT -0.05% Artivion NASDAQ:AORT VP, Chief Accounting Officer Amy Horton, sold 641 shares of common stock on March 2, 2026, at a price of $38.0249, for a total transaction value of $24,373. The transaction comes as the medical device company’s stock has surged 53% over the past year, though it currently trades at a premium P/E ratio of 182.1. Following the transaction, Horton directly owns 132,514 shares of Artivion. The sale was to cover tax withholding obligations related to the vesting of restricted stock units and does not represent a discretionary transaction. According to InvestingPro , the $1.84 billion market cap company appears overvalued at current levels based on Fair Value analysis. In other recent news, Artivion Inc. reported impressive fourth-quarter results for 2025, surpassing earnings expectations with an earnings per share of $0.17, well above the forecasted $0.06. The company achieved adjusted revenues of $118.3 million, marking an 18.5% year-over-year growth on a constant currency basis, even after excluding a one-time $2.3 million payment to the Italian government. This revenue figure exceeded both Canaccord Genuity’s estimate of $115.6 million and the consensus expectations of $116.5 million. However, Canaccord Genuity has lowered its price target for Artivion to $48 from $51, while maintaining a Buy rating, due to compressed multiples in comparable groups amid the recent stock market sell-off. Despite these developments, Art...